Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
Carrello
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Home
Riviste
European Pharmaceutical Journal
Volume 68 (2021): Numero 1 (January 2021)
Accesso libero
Phospholipid bilayers in model membranes and drug delivery systems: from physics to pharmacy
D. Uhríková
D. Uhríková
| 30 lug 2021
European Pharmaceutical Journal
Volume 68 (2021): Numero 1 (January 2021)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Article Category:
Special Issue Article
Pubblicato online:
30 lug 2021
Pagine:
66 - 71
Ricevuto:
16 giu 2021
Accettato:
17 giu 2021
DOI:
https://doi.org/10.2478/afpuc-2021-0008
Parole chiave
lipid bilayer
,
non-lamellar phases
,
antimicrobial peptides
,
lipoplexes
,
pulmonary surfactant
© 2021 D. Uhríková, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1
Lyotropic liquid crystalline mesophases: (A) multilamellar vesicles; (B) inverted hexagonal phase; (C) cubic phase of Pn3m space group.
Figure 2
(A) SANS curves of POPE/POPG vesicles; (B) CAM–POPE/POPG at P:L = 1:10 mol/mol (POPE/POPG = 3:1 mol/mol). Full lines represent fitting curves.
Figure 3
Multilamellar CAM–POPE/POPG structure identified at liquid crystalline state of the lipids (36 °C). d – repeat distance.
Figure 4
SAXS pattern of a mixture of LFchimera and DMPC/DMPG at P:L = 1:21 mol/mol (t = 24 °C). Peaks of detected cubic phases Pn3m (black) and Im3m (blue) are assigned to spacing √(h2 + k2 + l2), where h, k and l are Miller indices. Models of cubic phases of Pn3m and Im3m space group.
Figure 5
SAXS patterns of DNA–CnNO/DOPE complexes (n = 8, 10, 16 and 18) prepared at CnNO/DOPE = 0.4 mol/mol in aqueous solutions at acidic and neutral/slightly alkaline conditions, respectively. Transfection efficiency of CnNO/DOPE (n = 8–18) complexes tested on U2OS cells.
Figure 6
(A) Schematic representation of pulmonary surfactant; (B) SAXS pattern of modified porcine surfactant, surfactant incubated with 10% of LPS for 2 hours and surfactant/LPS 10% with addition of 2% of PxB (at 37 °C).